In addition, VCAM-1 expression correlated with tumorigenesis and poor prognosis in ovarian cancer [47, 48], and higher preoperative serum sVCAM-1 concentrations in ovarian cancer patients were linked to early tumor recurrence or disease progression [8]. Here, VCAM1 is linked to ovarian carcinoma.